Interventionelle und chirurgische Therapie non-kolorektaler Lebermetastasen

Zusammenfassung

In der Vergangenheit wurden Resektionen oder Transplantationen wegen non-kolorektaler Lebermetastasen durch die Abwägung von geringem Überlebensvorteil und Komplikationsrate eher zurückhaltend indiziert. Mittlerweile zählt die Leberchirurgie jedoch zu den komplikationsarmen Standardverfahren in der Tumortherapie, die unter Einbettung in multimodale Therapiekonzepte zu einer deutlichen Steigerung des Patientenüberlebens führen.

Publication History

Article published online:
04 October 2021

• Literatur

• 1 De Jong MC, Pulitano C, Ribero D. et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 2009; 250: 440-448
• 2 House MG, Ito H, Gonen M. et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1600 patients during two decades at a single institution. J Am Coll Surg 2010; 210: 744-752
• 3 Mazzaferro V, Sposito C, Coppa J. et al. The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors. Am J Transpl 2016; 16: 2892-2902
• 4 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 18: 242-251
• 5 Donadon M, Ribero D, Morris-Stiff G. et al. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer 2007; 1: 20-27
• 6 Adam R, Chiche L, Aloia T. et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model. Ann Surg 2006; 244: 524-535
• 7 Lendoire J, Moro M, Andriani O. et al. Liver resection for noncolorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford) 2007; 9: 435-439
• 8 Groeschl RT, Nachmany I, Steel JL. et al. Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 2012; 14: 769-777
• 9 Hoffmann K, Bulut S, Tekbas A. et al. Is hepatic resection for non-colorectal, non-neuroendocrine liver metastases justified?. Ann Surg Oncol 2015; 22 (Suppl. 03) S1083-S1092
• 10 Kassahun WT. Controversies in defining prognostic relevant selection criteria that determine long-term effectiveness of liver resection for noncolorectal nonneuroendocrine liver metastasis. Int J Surg 2015; 24: 85-90
• 11 Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?. J Hepatol 2007; 47: 460-466
• 12 Line PD, Hagness M, Berstad AE. et al. A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept. Ann Surg 2015; 262: e5-e9
• 13 Wilson JM, Carder P, Downey S. et al. Treatment of Metastatic Breast Cancer with Liver Transplantation. Breast J 2003; 9: 126-128
• 14 Husted TL, Neff G, Thomas MJ. et al. Liver Transplantation for Primary or Metastatic Sarcoma to the Liver. Am J Transplant 2006; 6: 392-397
• 15 Gao Q, Ren Z, Fan J. et al. Local and Systemic Therapies for Liver Metastases. Clin Surg 2016; 1: 1-7
• 16 Putzer D, Schullian P, Bale R. Locoregional ablative treatment of melanoma metastases. Int J Hyperthermia 2019; 36: 59-63
• 17 Andreou A, Denecke T, Seehofer D. Interventionelle und chirurgische Therapie nichtkolorektaler Lebermetastasen. Allgemein- und Viszeralchirurgie up2date 2013; 7: 99-118
• 18 Chamarthy MR, Kalva SP. Liver-Directed Therapy for Hepatic Malignancies. Am J Hematol/Oncol 2016; 12: 14-22
• 19 Ghidini M, Petrillo A, Salati M. et al. Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer:Myth, Hope, or Reality?. Cancers 2019; 11: 1095
• 20 Holzwanger DJ, Madoff DC. Role of interventional radiology in the management of hepatocellular carcinoma: current status. Chin Clin Oncol 2018; 7: 49
• 21 Wong J, Cooper A. Local Ablation for Solid Tumor Liver Metastases: Techniques and Treatment Efficacy. Cancer Control 2016; 23: 30-35
• 22 Pelage JP, Fohlen A, Mitry E. et al. Chemoembolization of neuroendocrine liver metastases using streptozocin and tris-acryl microspheres: Embozar (EMBOsphere + ZAnosaR) study. Cardiovasc Intervent Radiol 2017; 40: 394-400
• 23 De Baere T, Deschamps F, Teriitheau C. et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicineluting beads: preliminary results. J Vasc Interv Radiol 2008; 19: 855-861
• 24 Perälä J, Klemola R, Kallio R. et al. MRI-guided laser ablation of neuroendocrine tumor hepatic metastases. Acta Radiol Short Rep 2014; 3: 2047981613499753
• 25 Vogl TJ, Emam A, Naguib NN. et al. How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?. Viszeralmedizin 2015; 31: 406-413
• 26 Vogl TJ, Zangos S, Scholtz JE. et al. Chemosaturation with percutaneous hepatic perfusions of melphalan for hepatic metastases: experience from two European centers. Rofo 2014; 186: 937-944
• 27 Vogl TJ, Zangos S, Heller M. et al. Transarterial chemoperfusion with gemcitabine and mitomycin C in pancreatic carcinoma: results in locally recurrent tumors and advanced tumor stages. Rofo 2007; 179: 1181-1188
• 28 Vogl TJ, Heller M, Zangos S. et al. Transarterial chemoperfusion of inoperable pancreas carcinoma and local recurrence. Rofo 2003; 175: 695-704
• 29 Akahori T, Sho M, Tanaka T. et al. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors. Anticancer Res 2013; 33: 3355-3358
• 30 Azizi A, Naguib NN, Mbalisike E. et al. Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival rate. Pancreas 2011; 40: 1271-1275
• 31 Jarzabek M, Jargietto T, Wolski A. et al. Drug-eluting microspheres transarterial chemoembolization (DEM TACE) in patients with liver metastases. Pilot study. Pol J Radiol 2001; 76: 26-32
• 32 De Baere T, Deschamps F, Teritheau C. et al. Transarterial chemoembolization of liver metastases from well differentiated gastroentero-pancreatic endocrine tumors with doxorubicineluting beads: preliminary results. J Vasc Interv Radiol 2008; 19: 855-861
• 33 Kress O, Wagner HJ, Wied M. et al. Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors – a retrospective single-center analysis. Digestion 2003; 68: 94-101
• 34 Schuster R, Lindner M, Wacker F. et al. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome. Melanoma Res 2010; 20: 191-196
• 35 Huppert PE, Fierlbeck G, Pereira P. et al. Transarterial chemoembolization of liver metastases in patients with uveal melanoma. Eur J Radiol 2010; 74: e38-e44
• 36 Fiorentini G, Aliberti C, Del Conte A. et al. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study. In Vivo 2009; 23: 131-137
• 37 Vogl TJ, Eichler K, Zangos S. et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 2007; 133: 177-184
• 38 Patel K, Sullivan K, Berd D. et al. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 2005; 15: 297-304
• 39 Bale R, Putzer D, Schullian P. Local Treatment of Breast Cancer Liver Metastasis. Cancers 2019; 11: 1-15
• 40 Sim DPY, Goh BKP, Lee SY. et al. Preoperative Prognostic Factors After Liver Resection for Non-Colorectal, Non-Neuroendocrine Liver Metastases and Validation of the Adam Score in an Asian Population. World J Surg 2018; 42: 1073-1084
• 41 Oki E, Tokunaga S, Emi Y. et al. Surgical treatment of liver metastasis of gastric cancer. A retrospective multicenter cohort study (KSCC1302). Gastric Cancer 2016; 19: 968-976
• 42 Bauer S, Rutkowski P, Hohenberger P. et al. Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer 2012; 118: 3571-3578
• 43 Seesing MF, Tielen R, van Hillegersberg R. et al. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era. A nationwide retrospective study. Eur J Surg Oncol 2016; 42: 1407-1413
• 44 Ichida H, Umamura H, Yoshimoto J. et al. Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma. World J Surg 2013; 37: 398-407
• 45 Shrikhande SV, Kleeff J, Reiser C. et al. Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 2007; 14: 118-127
• 46 Hackert T, Niesen W, Hinz U. et al. Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol 2017; 43: 358-363
• 47 Mayo SC, De Jong MC, Pultano C. et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multiinstitutional analysis. Ann Surg Oncol 2010; 17: 3129-3136
• 48 Hartwig W, Denneberg M, Bergmann F. et al. Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease?. Am J Surg 2011; 202: 23-27
• 49 Seung Hoon C, Kim SM, Oh JT. et al. Solid pseudopapillary tumor of the pancreas: a multicenter study of 23 pediatric cases. J Pediatr Surg 2006; 41: 1992-1995
• 50 De Jong MC, Tsai S, Cameron JL. et al. Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol 2010; 102: 256-263
• 51 Hoffmann K, Franz C, Hinz U. et al. Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol 2010; 17: 1546-1554
• 52 Mariani P, Piperno-Neumann S, Servois V. et al. Surgical management of liver metastases from uveal melanoma: 16 years experience at the Institute Curie. Eur J Surg Oncol 2009; 35: 1192-1197
• 53 Pawlik TM, Vauthey JN, Abdalla EK. et al. Results of a single-center experience with resection and ablation for sarcoma metstatic to the liver. Arch Surg 2006; 141: 537-543
• 54 Staehler MD, Kruse J, Haseke N. et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12 year results from a retrospective comparative analysis. World J Urol 2010; 28: 543-547
• 55 Hahn TL, Jacobson L, Einhorn LH. et al. Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol 1999; 6: 640-644
• 56 Cai W, Tan Y, Ge W. et al. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study. Cancer Med 2018; 7: 2699-2709
• 57 Steinmüller T, Kianmanesh R, Falconi M. et al. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008; 87: 47-62
• 58 Elias D, Lasser P, Ducreux M. et al. Liver resection (and associated extrahepatic resections) for metastatic well differentiated endocrine tumors: a 15-year single-center prospective study. Surgery 2003; 133: 375-382
• 59 Touzios JG, Kiely JM, Pitt SC. et al. Neuroendocrine hepatic metastases: does aggressive management improve survival?. Ann Surg 2005; 241: 776-783
• 60 Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma. Transplantation 1998; 66: 1307-1312
• 61 Sposito C, Droz Dit Busset M, Citterio D. et al. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons. Rev Endocr Metab Disord 2017; 18: 473-483
• 62 Schemmer P, Friess H, Hinz U. et al. Stapler hepatectomy is a safe dissection technique: analysis of 300 patients. World J Surg 2006; 30: 419-430
• 63 Uggeri F, Ronchi PA, Goffredo P. et al. Metastatic liver disease from non-colorectal, non-neuroendocrine, non-sarcoma cancers: a systematic review. World J Surg Oncol 2015; 13: 191-198
• 64 Schöllnast H, Monette S, Ezell PC. et al. Acute and Subacute Effects of Irreversible Electroporation on Nerves: Experimental Study in a Pig Model. Radiology 2011; 260: 421-427